ALZN - Alzamend Neuro, Inc.
1.14
0.005 0.439%
Share volume: 31,213
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.37%
PREVIOUS CLOSE
CHG
CHG%
$1.14
0.00
0.00%
Summary score
26%
Profitability
18%
Dept financing
43%
Liquidity
32%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-72.17%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
106.44%
Debt ratio change over timeo
0%
Current Ratio
7.42%
Quick Ratio
0%
Cash Position Ratio
6.94%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-141.56%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
280.82%
Debt ratio change over timeo
0%
Current Ratio
1.48%
Quick Ratio
0%
Cash Position Ratio
1.25%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.19%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
25.06%
Debt ratio change over time
0%
Current Ratio
3.8%
Quick Ratio
0%
Cash Position Ratio
3.26%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALZN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 16.06% | 18.36% | 4.42% |
| Return on assets | -72.17% | 2.38% | 3.14% | 5.7% |
| Return on sales | 0% | 28.82% | 31.59% | 42.7% |
| Return on invested capital | 0% | 2.53% | 5.5% | 28.91% |
| Profitability | 0% | 51% | 62% | 81% |
| Total debt ratio | 106.44% | 90.78% | 91.15% | 24.68% |
| Debt ratio change over time | 0% | 479.62% | 17.73% | -0.03% |
| Dept financing | 25% | 46% | 22% | 6% |
| Current Ratio | 1.48% | 0.87% | 1.34% | 3.31% |
| Quick Ratio | 0% | 0.77% | 0.94% | 3.08% |
| Cash Position Ratio | 1.25% | 0.37% | 0.46% | 2.42% |
| Liquididy | 50% | 9% | 19% | 50% |
| Short-term ratios | ALZN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -1.65% |
| Return on assets | -141.56% | 1.68% | 1.29% | 4.78% |
| Return on sales | 0% | 25.19% | 18.03% | 40.54% |
| Return on invested capital | 0% | 0% | 0% | 4.62% |
| Profitability | 25% | 24% | 18% | 75% |
| Total debt ratio | 280.82% | 94.92% | 94.04% | 25.09% |
| Debt ratio change over time | 0% | 0% | 0% | -0.5% |
| Dept financing | 50% | 8% | 8% | 2% |
| Current Ratio | 1.48% | 0.87% | 1.34% | 3.31% |
| Quick Ratio | 0% | 0.77% | 0.94% | 3.08% |
| Cash Position Ratio | 1.25% | 0.37% | 0.46% | 2.42% |
| Liquididy | 24% | 17% | 23% | 75% |